Phase III study to evaluate the effect of 10 percent metronidazole ointment, applied topically three times a day in and around the anus and the change in perianal Crohn's disease activity

Trial Profile

Phase III study to evaluate the effect of 10 percent metronidazole ointment, applied topically three times a day in and around the anus and the change in perianal Crohn's disease activity

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Dec 2012

At a glance

  • Drugs Metronidazole (Primary)
  • Indications Crohn's disease
  • Focus Therapeutic Use
  • Sponsors SLA Pharma
  • Most Recent Events

    • 16 Oct 2008 Actual end date (Feb 2008) added as reported by ClinicalTrials.gov.
    • 16 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top